Publication | Open Access

Berberine administrated with different routes attenuates inhaled LPS-induced acute respiratory distress syndrome through TLR4/NF-κB and JAK2/STAT3 inhibition

Acute Lung InjuryInflammationDifferent Routes AttenuatesAnti-inflammatoryLung InflammationMedicineRespiratory ToxicologyImmunologyJak2/stat3 InhibitionPulmonary PharmacologyPulmonary FibrosisPharmacotherapyPharmacologyPulmonary Disease